V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007100 | 250005005 | 1.6 | null | Disease modification (D) | 2015-07-12 | 2015-07-12 | LENALIDOMIDE | 02 | N | 250031198 | AZACITIDINE |
| 250007101 | 250005006 | 1.77 | 75 | null | 2015-08-02 | 2015-08-07 | RUXOLITINIB | 02 | N | 250031205 | RUXOLITINIB |
| 250007102 | 250005007 | 1.76 | null | Curative (C) | 2017-02-09 | 2017-02-09 | CHOP R - 21 days | N | N | 250031207 | AZACITIDINE |
| 250007105 | 250005009 | null | 93.3 | null | 2015-04-07 | 2015-04-24 | Rituximab | null | N | 250031210 | PEG INTERFERON |
| 250007106 | 250005010 | 1.71 | 49.5 | Disease modification (D) | 2014-02-22 | 2014-02-22 | Azacitidine | 02 | N | 250031213 | CHOP R |
| 250007107 | 250009667 | 1.5 | null | Curative (C) | 2014-08-07 | 2014-08-18 | Rituximab | 02 | N | 250031214 | RUXOLITINIB |
| 250007108 | 250005011 | 1.63 | 95.9 | Palliative (P) | 2016-07-25 | 2016-07-25 | Cytarabine Low Dose | N | N | 250031216 | CHOP R |
| 250007109 | 250005012 | 1.72 | 0 | Disease modification (D) | 2016-11-11 | 2016-11-18 | Rituximab | 2 | N | 250031218 | ANAGRELIDE |
| 250007110 | 250005013 | 1.77 | 60 | Palliative (P) | 2015-07-01 | 2015-07-16 | RUXOLITINIB | N | N | 250031221 | RUXOLITINIB |
| 250007111 | 250005014 | null | null | null | null | 2014-01-08 | RUXOLITINIB | null | N | 250031222 | ALEMTUZUMAB |
| 250007112 | 250009668 | 1.57 | 0 | Palliative (P) | 2017-10-17 | 2017-12-01 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 250031225 | RUXOLITINIB |
| 250007113 | 250005015 | 0 | 103.7 | Neo-adjuvant (N) | 2017-12-18 | 2017-12-20 | PCV | 2 | N | 250031230 | TRIAL |
| 250007114 | 250005016 | -1 | 46.8 | Curative (C) | 2014-04-21 | 2014-04-30 | CHOP R - 21 days | 01 | null | 250031233 | FEC + DOCETAXEL |
| 250007115 | 250005017 | null | 85 | Disease modification (D) | 2015-07-03 | 2015-07-03 | LENALIDOMIDE | 02 | N | 250031244 | TRIAL |
| 250007116 | 250005018 | 1.65 | 75.7 | null | 2015-06-11 | 2015-06-11 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | N | N | 250031246 | IPM |
| 250007117 | 250009669 | 1.67 | 79.6 | Disease modification (D) | null | 2017-04-14 | RUXOLITINIB | null | N | 250031247 | BUSULPHAN |
| 250007118 | 250005019 | 1.71 | null | Disease modification (D) | 2015-08-23 | 2015-09-01 | RUXOLITINIB | 2 | null | 250031251 | NHL 2003 |
| 250007119 | 250005020 | null | null | Curative (C) | 2018-02-26 | 2018-03-07 | Rituximab (Maintenance) | N | N | 250031252 | CVD |
| 250007120 | 250005021 | 1.5 | 80.1 | Curative (C) | 2018-01-04 | 2018-01-04 | PEG INTERFERON | 2 | N | 250031255 | TRIAL |
| 250007121 | 250005022 | null | null | Neo-adjuvant (N) | 2017-03-21 | 2017-03-21 | RUXOLITINIB | 02 | N | 250031257 | BUSULPHAN |
| 250007122 | 250009670 | 1.5 | 0 | Palliative (P) | 2018-01-19 | 2018-01-19 | Rituximab | 02 | N | 250031258 | RITUXIMAB |
| 250007123 | 250005023 | 1.69 | 54 | null | 2014-06-11 | 2014-06-11 | RUXOLITINIB | Y | N | 250031259 | TRIAL |
| 250007124 | 250005024 | 1.62 | 93.6 | Disease modification (D) | 2014-05-01 | 2014-05-01 | Bendamustine+Rituximab (1st Course) | N | N | 250031261 | BENDAMUSTINE + RITUXIMAB |
| 250007125 | 250005025 | null | 67.3 | Disease modification (D) | 2014-07-22 | 2014-08-02 | Carboplatin AUC 2 - 5 | 2 | N | 250031266 | IPILIMUMAB |
| 250007126 | 250005026 | 1.7 | 93.2 | Curative (C) | 2015-03-22 | 2015-04-27 | PEG INTERFERON | N | N | 250031268 | RUXOLITINIB |
| 250007127 | 250005027 | 1.83 | 101.4 | Palliative (P) | 2013-02-15 | 2013-02-15 | RUXOLITINIB | N | N | 250031269 | RITUXIMAB |
| 250007128 | 250005028 | 1.5 | 73.1 | Palliative (P) | 2017-11-23 | 2017-11-23 | PEG INTERFERON | 02 | null | 250031270 | RITUXIMAB |
| 250007129 | 250005029 | 1.67 | 32.8 | null | 2017-10-17 | 2017-10-17 | CVP R | 2 | N | 250031273 | RUXOLITINIB |
| 250007130 | 250005030 | 1.75 | 97.5 | Palliative (P) | 2015-03-02 | 2015-03-02 | RUXOLITINIB | N | N | 250031274 | RITUXIMAB |
| 250007131 | 250005030 | 1.72 | 0 | Palliative (P) | 2015-07-29 | 2015-08-25 | ECX | N | N | 250031274 | CYTARABINE |
| 250007132 | 250011587 | 1.8 | 76.6 | Curative (C) | 2014-12-10 | 2014-12-29 | AML16 Azacitidine | 2 | N | 250031279 | RUXOLITINIB |
| 250007133 | 250005031 | 1.66 | 71.3 | Disease modification (D) | 2014-08-04 | 2014-08-04 | ANAGRELIDE | 2 | N | 250031282 | TRIAL |
| 250007134 | 250005032 | null | 60 | Adjuvant (A) | 2013-04-09 | 2013-05-04 | RUXOLITINIB | N | null | 250031288 | RUXOLITINIB |
| 250007136 | 250005034 | 0 | 65 | Curative (C) | 2014-11-21 | 2014-11-21 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 250031294 | BUSULPHAN |
| 250007137 | 250009672 | null | null | Curative (C) | null | 2015-10-20 | RUXOLITINIB | Y | N | 250031298 | RUXOLITINIB |
| 250007138 | 250005035 | 1.8 | 40 | Palliative (P) | 2015-12-01 | 2015-12-01 | BUSULFAN | 02 | N | 250031299 | RUXOLITINIB |
| 250007139 | 250005036 | 1.82 | 68 | Palliative (P) | 2015-11-14 | 2015-12-20 | BORTEZOMIB + THALIDOMIDE | null | N | 250031300 | RUXOLITINIB |
| 250007140 | 250005036 | 1.73 | 0 | Curative (C) | 2013-12-09 | 2013-12-10 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 250031300 | IPM |
| 250007141 | 250005037 | 1.66 | 76 | Curative (C) | 2015-12-31 | 2015-12-31 | BUSULFAN | N | N | 250031308 | RUXOLITINIB |
| 250007142 | 250005038 | 1.6 | 80 | Palliative (P) | 2015-08-12 | 2015-08-13 | Rituximab | N | N | 250031309 | THALIDOMIDE |
| 250007143 | 250005038 | 0 | 70.6 | Palliative (P) | 2014-11-25 | 2014-12-30 | RUXOLITINIB | N | N | 250031309 | BUSULPHAN |
| 250007144 | 250005038 | 1.53 | 98.9 | null | 2018-10-22 | 2018-10-22 | DA | N | N | 250031309 | LI-1 TRIAL |
| 250007145 | 250005038 | 1.69 | 0 | null | 2016-04-01 | 2016-04-01 | Busulfan Oral | Y | null | 250031309 | RUXOLITINIB |
| 250007146 | 250005038 | 1.66 | 54 | Disease modification (D) | 2017-07-25 | 2017-07-25 | RUXOLITINIB | Y | N | 250031309 | RUXOLITINIB |
| 250007147 | 250005039 | 1.61 | null | Palliative (P) | 2018-01-15 | 2018-01-15 | PEG INTERFERON | 02 | N | 250031315 | RUXOLITINIB |
| 250007148 | 250005040 | 1.81 | 84.8 | Curative (C) | 2016-03-11 | 2016-03-11 | RUXOLITINIB | N | N | 250031316 | INTERFERON |
| 250007149 | 250005041 | null | null | Disease modification (D) | 2017-10-09 | 2017-10-09 | Rituximab | Y | N | 250031317 | PEG INTERFERON |
| 250007150 | 250005042 | null | null | Curative (C) | 2018-04-09 | 2018-04-09 | RUXOLITINIB | null | N | 250031321 | BUSULPHAN |
| 250007151 | 250005042 | 1.74 | 51.8 | null | 2016-12-31 | 2017-01-03 | RUXOLITINIB | N | null | 250031321 | PEG INTERFERON |
| 250007152 | 250005042 | 1.63 | 88.3 | Disease modification (D) | 2017-07-18 | 2017-07-18 | INTERFERON | N | N | 250031321 | RUXOLITINIB |